September FDA plays >>> Link back for August plays 09/05/2012 Novartis AG NVS Tobramycin inhalation powder (NDA) FDA panel to review Tobramycin inhalation powder for mgmt of cystic fibrosis patients infected with Pseudomonas aeruginosa stockcharts.com/c-sc/sc?s=NVS&p=D&yr=0&mn=6&dy=0&i=p01813241639&a=275794091&r=1346110679657 09/05/2012 Salix Pharmaceuticals Ltd SLXP Crofelemer 125 mg tablets (NDA) FDA decision on Crofelemer for control and symptomatic relief of diarrhea in patients with HIV/AIDS on anti-retroviral therapy stockcharts.com/c-sc/sc?s=SLXP&p=D&yr=0&mn=6&dy=0&i=p98397332973&a=275794112&r=1346110708241 09/09/2012 Ironwood Pharmaceuticals, Inc. IRWD Linaclotide (NDA) FDA decision on Linaclotide for treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation stockcharts.com/c-sc/sc?s=IRWD&p=D&yr=0&mn=6&dy=0&i=p43346393508&a=275794125&r=1346110738258 09/10/2012 Navidea Biopharmaceuticals, Inc. NEOP, NAVB Lymphoseek (NDA) FDA decision on Lymphoseek for proposed use in intraoperative lymphatic mapping stockcharts.com/c-sc/sc?s=NAVB&p=D&yr=0&mn=6&dy=0&i=p54789262233&a=275794161&r=1346110799648 09/13/2012 Cornerstone Therapeutics Inc. CRTX Lixivaptan (CRTX 080) (NDA) FDA panel to review Lixivaptan for treatment of hyponatremia stockcharts.com/c-sc/sc?s=CRTX&p=D&yr=0&mn=6&dy=0&i=p82649548381&a=275794185&r=1346110842042 09/14/2012 Gilead Sciences Inc. GILD Truvada (sNDA) FDA decision on Truvada in new indication as HIV preventive therapy *FDA approved Truvada as HIV preventive therapy on Jul.16 09/30/2012 NPS Pharmaceuticals Inc NPSP Gattex (NDA) FDA decision on Gattex for proposed treatment of adult short bowel syndrome *FDA decision date postponed to Dec.30, 2012